FP433
2462
Dr.Shwetha G R
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 2462 | Dr.Shwetha G R | shwetha.gr.hims@gmail.com | 9916458192 |
Surgical Retina
PREOPERATIVE 0.1% BRIMONIDINE FOR HEMOSTASIS IN DIABETIC VITRECTOMY- A RANDOMISED CONTROLLED TRIAL
Purpose- To evaluate efficacy of preoperative 0.1% Brimonidine in improving intraoperative hemostasis during Diabetic vitrectomy. Methods- Patients undergoing vitrectomy were allocated to 4 groups: Group A, preoperative 0.5% CMC drops; Group B, preoperative 0.1% Brimonidine drops; Group C, preoperative antiVEGF; Group D, both antiVEGF and Brimonidine was used. Hemostasis was assessed indirectly using surgical duration, need for intraoperative IOP elevation, infusion fluid quantity, instrument exchanges and surgeon-rated ease of surgery. Results- Each group had 20 patients. Bonferroni analysis showed that Group D had shortest surgical duration, the least need for IOP elevation and best surgical ease. Infusion fluid use and instrument exchanges were lowest in Group B and D respectively. Conclusion- Preoperative 0.1% Brimonidine is a safe and effective strategy to improve intraoperative hemostasis during diabetic vitrectomy, particularly when combined with intravitreal antiVEGF.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 1721 | Dr.Rajesh Ramanjulu | drragraj@gmail.com | 9036952706 |